Dacogen and Neulasta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dacogen (decitabine) and Neulasta (pegfilgrastim). Common drug interactions include pyrexia among females and white blood cell count decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Dacogen and Neulasta. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Dacogen?

Dacogen has active ingredients of decitabine. eHealthMe is studying from 1,541 Dacogen users. Check the latest studies of Dacogen.

What is Neulasta?

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.

On Jul, 09, 2026

41 people who take Dacogen and Neulasta together, and have interactions are studied.

What are the common drug interactions of Dacogen and Neulasta, by gender? *:

female:

Pyrexia (fever)
Drug ineffective
Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
White blood cell count decreased
Death
Fungal infection
Pain in extremity
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Anaemia (lack of blood)

male:

White blood cell count decreased
Death
Platelet count decreased
Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)
White blood cell count increased
Device occlusion
Pain in extremity
Anaemia (lack of blood)
Aphagia (inability or refusal to swallow)

What are the common drug interactions of Dacogen and Neulasta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Death
Pyrexia (fever)
Thrombocytopenia (decrease of platelets in blood)
Device occlusion
Aphagia (inability or refusal to swallow)
Application site discomfort
Asthenia (weakness)
Blast cell crisis
Blood lactate dehydrogenase increased
Bone marrow failure

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 23 people, 56.10%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 10 people, 24.39%
Nausea (feeling of having an urge to vomit): 7 people, 17.07%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 17.07%
Essential Thrombocythaemia (chronic blood cancer): 6 people, 14.63%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 3 people, 7.32%
Neoplasm Malignant (cancer tumour): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Dacogen and Neulasta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously